Delivery Order SPE2DR25D2006-SPE2DR26F56AV
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $1,324.81. This firm fixed-price delivery order, with an ultimate completion date of November 14, 2025, was competitively awarded with no set-aside designation and represents a continuation of AmerisourceBergen's critical role as a pharmaceutical supplier to federal medical procurement. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Rifampin 300 mg capsules in unit dose packaging (100-count), with a contract ceiling value of $28,600.52. This firm fixed-price delivery order, with an ultimate completion date of September 17, 2025, represents a competitively awarded, non-set-aside procurement supporting federal pharmaceutical supply needs. The work will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $13,755.84. This competitively awarded, firm fixed-price delivery order is set to be completed by July 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of the company's pharmaceutical supply services under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $3,619.94. This is a firm fixed-price delivery order with an ultimate completion date of November 5, 2025, and represents a competitive award with no set-aside designation. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $31,201.41. This is a firm fixed price delivery order with no set-aside designation, representing a competitively awarded contract under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The ultimate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Rifampin 150 mg capsules in quantities of 30 units. This non-set-aside, competitively awarded contract is structured as a firm fixed-price delivery order with a ceiling value of $1,137.07 and an ultimate completion date of September 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $11,897.40. This firm fixed-price delivery order represents a non-competitive, non-set-aside procurement with an ultimate completion date of November 14, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Rifampin 300 mg capsules (60-count) with a ceiling value of $7,799.66. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for completion by September 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Rifampin 300 mg capsules in unit dose packages of 100 units. This competitively awarded contract, valued at $2,276.64 with firm fixed pricing, represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The order is scheduled for completion by August 18, 2025, with fulfillment performed at the contractor's facility in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,516.87 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) under a firm fixed-price contract. The award was issued on June 20, 2025, with an ultimate completion date of June 23, 2025. This non-set-aside competitive award represents a routine pharmaceutical procurement through DLA's medical supply chain, with performance to occur at the contractor's facility in Conshohocken,...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F56AVDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a contract value of $2,637.10. This is a firm fixed-price delivery order with an ultimate completion date of November 14, 2025, and no set-aside designation was utilized. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The Rifampin delivery supports DLA's ongoing medical supply chain requirements for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 11/13/25 |